Indiana Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Indiana Healthcare Today.

Press releases published on September 15, 2026

5 hours ago

SCYNEXIS Appoints Todd Minga, M.D., as Senior Vice President, Research & Development

Indeterminate GlobeNewswire

5 hours ago

Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility

Indeterminate GlobeNewswire

6 hours ago

Orvida Pharma Announces Interim Financing Led by Recordati to Advance Ontivatrep Development for Rare Genetic Skin Diseases

Indeterminate GlobeNewswire

6 hours ago

Avicanna to Present at a Life Sciences Investor Forum on September 17, 2026

Indeterminate GlobeNewswire

6 hours ago

BioVie Announces Topline Results from Phase 2 ADDRESS‑LC Trial Evaluating Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID

Indeterminate GlobeNewswire

6 hours ago

Ontario Healthcare Stakeholders Unite on Shared Action Plan to Reduce Tobacco and Nicotine Dependence

Indeterminate GlobeNewswire

6 hours ago

PolarityBio Announces FDA Acceptance for Filing of SkinTE® BLA with Priority Review in Diabetic Foot Ulcers

Indeterminate GlobeNewswire

6 hours ago

Axiom Biosciences Expands Manufacturing and Clinical Development Capabilities Through Partnership with GeneFab

Indeterminate GlobeNewswire

6 hours ago

Quantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus™

Indeterminate GlobeNewswire

6 hours ago

Remedy Plan Therapeutics Announces Multiple Development and Corporate Milestones as First-In-Class Hyperbolic NAMPT Inhibitor, RPT1G, Advances in Phase 1 Dose Escalation Trial in AML/MDS

Indeterminate GlobeNewswire

6 hours ago

BlossomHill Therapeutics Presents Updated Data from Ongoing Phase 1/2 SOLARA Trial Demonstrating Encouraging Anti-Tumor Activity of OMNI-EGFR™ Inhibitor BH-30643 in EGFR C797S-Positive NSCLC at IASLC 2026 World Conference on Lung Cancer

Indeterminate GlobeNewswire

6 hours ago

Satellos to Present at the 31st Annual Congress of the World Muscle Society

Indeterminate GlobeNewswire

6 hours ago

Juniper Biosciences Unveils JBS-002 and JBS-004, Advancing Two Late-Stage Diagnostic Programs to Registration Batch Manufacturing in the Fourth Quarter of 2026

Indeterminate GlobeNewswire

6 hours ago

Art Meets Whiskey: Breckenridge Distillery Debuts Limited-Edition Collectors Series Release with Pat Milbery

Indeterminate GlobeNewswire

6 hours ago

VitalHub Announces Expansion of AI Capabilities with Launch of AI Scribe

Indeterminate GlobeNewswire

6 hours ago

Ocular Therapeutix™ Announces Positive Pre-NDA Meeting with U.S. FDA for AXPAXLI™ in Wet AMD

Indeterminate GlobeNewswire

6 hours ago

Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adult and Adolescent Participants with Asthma and Type 2 Inflammation

Indeterminate GlobeNewswire

6 hours ago

Serapha Bio Appoints Kenneth T. Mills as Chief Executive Officer and Names Senior Leadership Team to Advance Potential Best-in-Class in vivo Base Editing Program for Alpha-1 Antitrypsin Deficiency

Indeterminate GlobeNewswire

7 hours ago

Walden Biosciences Announces CMO Appointment and Upcoming Clinical Data for WAL0921 in Proteinuric Chronic Kidney Disease

Indeterminate GlobeNewswire

7 hours ago

Vera Therapeutics Announces TRUTAKNA™ (atacicept-vymj) Stabilized eGFR and Prevented Kidney Disease Progression Through Two Years in ORIGIN 3 Final Efficacy Analysis in IgA Nephropathy

Indeterminate GlobeNewswire